Stockreport

Rhythm Pharmaceuticals: Rare Genetic Obesity Player With Upcoming PDUFA [Seeking Alpha]

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com
PDF The FDA has accepted RYTM's sNDA for setmelanotide in acquired hypothalamic obesity, with a PDUFA goal date of 12/20/2025. I expect RYTM's recent share malaise to con [Read more]